ExtrAperitoneaL Plasty vs Intraperitoneal oNlay mEsh in Ventral Hernia Repair
Launched by UNIVERSITY HOSPITAL, BASEL, SWITZERLAND · Apr 11, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different surgical methods for repairing ventral hernias, which are bulges that can occur in the abdominal wall. The trial compares the eTEP (Extended totally extraperitoneal repair) technique and the IPOM (Intraperitoneal onlay mesh) technique to see which one leads to better outcomes, such as less pain after surgery, fewer complications, lower chances of the hernia coming back, and overall quality of life improvements.
To participate, you need to be over 18 years old and have a specific type of ventral hernia that meets certain size requirements. The surgeons involved in this trial are experienced in both methods, ensuring you receive skilled care. If you join, you will have the surgery using one of the techniques and then have follow-up appointments or check-ins at various times over the next five years to monitor your recovery and health outcomes. This study aims to provide valuable information that could help improve hernia repair surgeries in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient age \>18 years
- • Informed consent obtained
- • Primary or incisional ventral hernia
- • Epigastric, umbilical or infraumbilical ventral hernias with transversal diameter \>1cm and \</= 4cm, +/- rectus diastasis which doesn't demand specific treatment
- • If multiple hernias: cumulative transversal diameter \</= 4cm
- • Considered eligible for minimally-invasive approach
- Exclusion Criteria:
- • Subxyphoidal or suprapubic hernias
- • precedent hernia treatment with mesh placement in the retromuscular space
- • liver disease defined by the presence of ascites
- • end-stage renal disease requiring dialysis
- • need of an emergency surgery
- • pregnancy
- • need of rectus diastasis treatment intraoperatively
- • Criteria for participating surgeons
- • - Each participating surgeon has performed 20 or more laparoscopic IPOM procedures and 20 or more eTEP procedures.
About University Hospital, Basel, Switzerland
The University Hospital Basel, Switzerland, is a leading academic medical center renowned for its commitment to cutting-edge research and innovative patient care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise and state-of-the-art facilities to advance medical knowledge and therapeutic options across various disciplines. With a collaborative approach that integrates clinical practice and scientific inquiry, the University Hospital Basel fosters an environment conducive to rigorous clinical trials, ensuring the highest standards of safety and efficacy. Its strategic focus on patient-centered research aims to translate scientific discoveries into tangible health solutions, benefiting both local and global communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Basel, Basel Stadt, Switzerland
Patients applied
Trial Officials
Julian Süsstrunk, MD
Principal Investigator
Clarunis - Universitäres Bauchzentrum Basel
Johannes Baur, MD
Principal Investigator
Clarunis - Universitäres Bauchzentrum Basel
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported